Surgically Targeted Radiation Therapy (STaRT)
GammaTile Therapy
Education
Learn more about GammaTile Therapy
We invite you to browse through the videos, read the FAQs, and take a deep dive into the science behind GammaTile Therapy by watching the webinars and reading the clinical publications.
Note: In January 2020, GammaTile Therapy was FDA cleared for the treatment of newly diagnosed malignant brain tumors of all types in addition to the existing clearance for recurrent brain tumors.
Physician Interviews
WeTV National | March 21, 2020 | New Approach for the Treatment of Brain Tumors” on The Lifestyle List
March 18, 2020 | GammaTile Therapy Physician Testimonial | Dr. McCracken, Neurosurgeon At Piedmont Atlanta Hospital
Ohio CBS | November 15, 2019 | New brain cancer therapy provides radiation right at site of tumor
Ohio CBS | August 20, 2019 | Mayfield brain and spine neurosurgeon using new radiation therapy.
Florida NBC | March 20, 2020 | GammaTile: New Approach For The Treatment Of Brain Tumors
North Carolina CBS | January 24, 2020 | Vidant Health™ and the ECU Brody School of Medicine successfully perform first-in-state GammaTile procedure
Cronkite News Division of Arizona PBS | Oct 22, 2019 | Battling brain tumors with time-released radiation
Arizona CBS | August 14, 2019 | New therapy to slow down brain tumors forever changes Arizona woman's life.
Minnesota CBS | February 14, 2019 | New brain cancer treatment GammaTile Therapy at University of Minnesota with survivor Linda Tinega.
Physician Testimonial Video
Dr Clark Chen, University of Minnesota
Introducing GammaTile Therapy
GammaTile Technology
GammaTile Science
Surgical Footage
Glioma Case Example I
Glioma Case Example II
Brain Metastases Case Example
Meningioma Case Example
“What I like about GammaTile is that they’re taking a radiation technology that already exists and making it safer and easier to deliver…Should be equally effective and faster to implant after tumor surgery…[It’s] better for patients (less anesthesia time) and safer for the staff (less exposure in the operating room).”
Dr Helen Shih
Radiation Oncologist, Massachusetts General Hospital
FAQs
Below are the answers to important questions about GammaTile Therapy for people with brain tumors and their caregivers. Speak with your treatment team to see if GammaTile Therapy is right for you or your loved one.
Frequently asked questions
#demo.question.question1#
#demo.question.question1.answer1#
#demo.question.question2#
#demo.question.question2.answer1#
-
#demo.question.question2.answer2# -
#demo.question.question2.answer3# -
#demo.question.question2.answer4# -
#demo.question.question2.answer5#
#demo.question.question3#
#demo.question.question3.answer0#
-
#demo.question.question3.answer1# -
#demo.question.question3.answer2# -
#demo.question.question3.answer3# -
#demo.question.question3.answer4# -
#demo.question.question3.answer5#
#demo.question.question4#
#demo.question.question4.answer1#
Webinars
American Brain Tumor Association | February 27, 2020
Webinar: Therapies Given During Surgery
This webinar provides a detailed overview of surgically implanted brain tumor therapies, including GammaTile Surgically Targeted Radiation Therapy (STaRT). Dr John A. Boockvar, the director of the Brain Tumor and Pituitary/Neuroendocrine Center at Lenox Hill, discusses various treatment options, highlights their differences, and provides guidance on how patients can talk with their heath team about their care plan. Watch here
The Musella Foundation | May 26, 2019
Webinar: GammaTiles for Brain Tumors
This webinar provides a detailed overview of surgically implanted brain tumor therapies, including GammaTile Surgically Targeted Radiation Therapy (STaRT). Dr John A. Boockvar, the director of the Brain Tumor and Pituitary/Neuroendocrine Center at Lenox Hill, discusses various treatment options, highlights their differences, and provides guidance on how patients can talk with their heath team about their care plan. Watch here
Clinical Publications
JOURNAL OF NEUROSURGERY 2019
Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas
David G. Brachman, MD, Emad Youssef, MD, Christopher J. Dardis, MD, Nader Sanai, MD, Joseph M. Zabramski, MD, Kris A. Smith, MD, Andrew S. Little, MD, Andrew G. Shetter, MD, Theresa Thomas, MS, Heyoung L. McBride, MD, MS, Stephen Sorensen, PhD, Robert F. Spetzler, MD, and Peter Nakaji, MDl, in the Journal of Neurosurgery. 2018:1-10. doi:10.3171/2018.7.jns18656. Read here
AANS ANNUAL MEETINGS 2019 – 2020
Surgically targeted radiation therapy: a prospective trial in 79 recurrent, previously irradiated intracranial neoplasms on a prospective clinical trial
AANS Annual Meeting 2019. Read here
AANS Annual Meeting 2020. Read here
ABS ANNUAL MEETING 2019
Surgically targeted radiation therapy: safety profile of collagen tile brachytherapy in 79 recurrent, previously irradiated intracranial neoplasms on a prospective clinical trial.
ABS Annual Meeting 2019. Read here
SNO ANNUAL MEETING 2019
RTHP-32. First experience with gamma tile permanent implants for recurrent brain tumors
Clara Ferreira, Parham Alaei, Clark Chen, Margaret Reynolds, David Sterling, Kathryn Dusenbery, Neuro-Oncology. Volume 21, Issue Supplement_6, November 2019, Page vi216, doi:10.1093/neuonc/noz175.903.